EssilorLuxottica has announced it now holds an almost 100% stake in GrandVision after the completion of a mandatory public offer period, opening the door to delist shares in the optical retailer on the Amsterdam Stock Exchange. Read more
Analysis examines COVID protective effect of face shields and eye protection
New research evaluating the effect of eye protection on COVID-19 transmission among healthcare workers has found face shields may have a substantial protective effect, which could also be down to their additional inhalation protection. Read more
New findings ‘alter forever how we think of MIGS’ – Dr Ike Ahmed
Ivantis has revealed new data from its five-year HORIZON pivotal trial showing its Hydrus Microstent device lowers the rate of visual field loss by 47% versus cataract surgery alone. Read more
Researchers develop inexpensive, fast method to make freeform optics
Researchers who set out to find a simple method for fabricating high quality freeform optics that don’t rely on mechanical processing or expensive infrastructure have exceeded their goal. Read more
Contact lenses favoured over spectacles with mask wear
A new study has established that wearing contact lenses offers better vision correction than spectacles when paired with face masks and doing so likely improves adherence to mask use. Read more
Alcon to acquire Hydrus Microstent MIGS device for AU$640 million
Multinational ophthalmic company Alcon has agreed to acquire privately-owned Californian firm Ivantis – and its Hydrus Microstent minimally invasive glaucoma surgery (MIGS) device – for an initial US$475 million (AU$640 m). Read more
Seven-year study shows no myopia control rebound in children wearing MiSight contact lens
New seven-year findings from CooperVision’s MiSight 1 day contact lens clinical trial shows no evidence of myopia control rebound in children 12 months after treatment has ended. Read more
FDA approves first presbyopia eye drop
US regulators have approved the country’s first presbyopia eye drop that adopts pupil constriction to improve near and intermediate vision while maintaining some pupillary response to different lighting conditions. Read more
FDA approves Susvimo continuous drug delivery implant for AMD
The US Food and Drug Administration (FDA) has approved the Susvimo implant which delivers ranibizumab continuously, offering patients living with neovascular age-related macular degeneration (nAMD) an alternative to more frequent anti-VEGF eye injections. Read more
Specsavers Canada wants to open 200 stores by 2024
After announcing its entrance into the North American market earlier this year, Specsavers has set a goal to open 200 stores across Canada over the next three years. Read more